A Retrospective Evaluation of Therapeutic Efficacy and Safety of Chemoradiotherapy in Older Patients (aged ≥ 75 Years) With Limited-Disease Small Cell Lung Cancer: Insights from Two Institutions: Chemoradiotherapy in Older Patients With Limited-Disease Small Cell Lung Cancer. Radiol Oncol 2024, 58 (3), 432-443.